Thank you for joining us for our first quarter 2021 results call. As usual, our Chief Executive Officer, Christian Sewing, will speak first, followed by our Chief Financial Officer, James von Moltke. The presentation, as always, is available for download in the Investor Relations section of our website, db.com. Before we get started, let me just remind you that the presentation contains forward-looking statements, which may not develop as we currently expect. We therefore ask you to take notice of the precautionary warning at the end of our materials.

Thank you, Ioana. A warm welcome from me as well. It's a pleasure to be discussing our first quarter 2021 results with you today. We gave ourselves 14 quarters to transform Deutsche Bank and seven quarters are now behind us. Halfway through our time frame, we have already completed much of the transformation journey. We have continued to deliver against our transformation milestones. We are on or ahead of our expected time line on all key measures. We said at the Investor Deep Dive in December we would focus on delivering sustainable profitability. With revenue growth in the quarter up 14% to €7.2 billion, we demonstrated what this franchise is capable of. We generated €1.6 billion of pretax profit and €1 billion of profit after tax. That's our best quarter in seven years despite our now smaller footprint. That enabled us to generate meaningful capital from net income, which helped us strengthen our capital ratio in the quarter. Excluding the bank levy, our pretax profit is €2.2 billion, demonstrating our strong operating performance. We also made progress on costs. Our adjusted costs, excluding transformation charges and bank levies, reduced from €4.9 billion to €4.6 billion year-on-year, in line with the path we provided with our fourth quarter 2020 results. We remain disciplined on capital, risk and balance sheet management, and we successfully navigated several market events during the quarter. We are delivering on our path to higher return on tangible equity for the group with progress to a sustainable profitability. This quarter, we generated a 7.4% return on tangible equity, including full recognition of the annual bank levy. Progress across all business in the first quarter reinforces our confidence that our strategic path is the right one. Now let me take you through some of the highlights from this quarter on Slide 2. We continue to remain fully focused on executing our transformation strategy and delivering on our 2022 targets and ambitions. Our progress this quarter shows that they are well within reach. Refocusing our business around core strength is paying off. Our revenues of €7.2 billion fully support our trajectory for the 2022 revenue goal. Our adjusted costs, excluding transformation charges and bank levies, have reduced by roughly 4% year-on-year, in line with our cost ambition for 2022, as we outlined at the Investor Deep Dive. We continue to benefit from our leading risk management capabilities. Provision for credit losses was €69 million this quarter, down 86% from the first quarter of 2020. We have seen a more constructive credit environment than we initially expected, which has allowed us to lower our expectations for provisions for 2021, although we continue to see uncertainties in the operating environment. We improved our cost-to-income ratio to 77% for the quarter, which leaves us well positioned to meet our 2022 target of 70%. The Core Bank achieved a 71% cost income ratio.

Thank you, Christian. Let me start with a summary of our financial performance for the quarter compared to the prior year on Slide 10. As Christian said, we remain focused on delivering sustainable profitability. We generated a profit before tax of €1.6 billion, or €1.8 billion on an adjusted basis.

Thank you, James. Operator, we are now ready to take your questions.

And the first question comes from the line of Daniele Brupbacher of UBS.

I have to say plus 9% on results day is definitely a statement. So well done with these results, impressive. I would ask three questions. One on revenues, one on dividend and one on regulatory RWA inflation. And on the revenue side, I think obviously, we are not too far away from 2022, and I think a key debate in the market has been revenue sustainability. I guess all you can do is to deliver good results quarter after quarter. So I was just wondering whether you could talk a little bit how the second quarter has started, what your expectation is and sort of probably by key revenue pockets. That would be helpful. And then on the dividend, if I saw that right, you accrued €300 million in the first quarter. I think also quite a statement, if I got that right there. But how do -- how should we think about dividend accrual for the rest of the year? Is there a pattern we should expect? And then very lastly, James, you mentioned the 80 bps impact in the second quarter. I think that's well understood. If we go out a bit longer term, what else is coming down the road? I'm thinking about fundamentally the trading book, probably. What else is going to kind of hit you at some point down the road?

Thank you, Daniele, and thank you for your comments and questions. Let me take the revenue question. You know our habit, and I think good habit, not to guide on quarters or four quarters. But let me try to answer your question in this way. So obviously, versus Q1, we will see a certain normalization of revenues in the Investment Bank. Nevertheless, and I think that is what really creates also our momentum, we are very encouraged by the robustness and sustainability of our revenues in the Investment Bank, and we see the momentum and the steady development in all stable business, be it Asset Management, Corporate and Private Bank. And in this regard, having this in our eyes and looking at the statements we made today, we believe that based on the Q1 performance in the Investment Bank, we are confident that we will achieve revenues for the year which are kind of in line or flattish to last year or very close to last year. And if you then look at the other three businesses, how they have actually developed in Q1. Take James' comment into account that actually, the interest rate headwind is reducing over time now, in particular in the Corporate Bank, then followed by the Private Bank. Our compensating measures like deposit repricing is working well. Actually, we are doing even more on this one. Our growth initiatives in all three stable businesses are working and are bearing fruits. That actually tells me that all the individual revenue goals which we have given in the Investor Day for 2022, we have an even higher confidence in achieving that. And that counts for Asset Management, that counts for the Private Bank, that accounts for the Corporate Bank. And then now taking again a view at the Investment Bank, with the guidance we have given this morning for the full year 2021, and then thinking that our expectation for 2022 was, I think, around €8. 5 billion, with the robustness and sustainability of revenues which we also see now in these days, we feel very confident to achieve that what we told you in the Investor Day for 2022, and hence, our confidence is even higher than before.

Daniele, on your other questions -- thank you for the question. I would actually only add that just looking at Q2 last year, there are some interesting dynamics. As you know, IB has a tough comp, PB actually an easier comp because there were some unusual items in the revenue line last year. Corporate Bank does continue to have some pressure on rates or revenues in -- or interest rate revenues in Q2. And then Asset Management has a good run rate. As Christian just mentioned, fair value of guarantee has resulted in a little bit of swing. So you have to sort of adjust for that in Q2. The other thing I just mentioned is TLTRO-III doesn't -- revenues don't repeat in Q2 to the extent that we had them in Q1. It was a total of about €125 million in revenues based on the catch-up in Q1. We think that will -- the kicker will step down to about €50 million in revenue in Q2. So it's a few dynamics I just want to highlight for you all. On the dividend, we have a relatively mechanical accrual for the common stock dividend based on some rules that we have from the ECB. So we're going to accrue for the balance of the year at 33% of net income after the AT1 coupon accrual. That AT1 coupon accrual is running at about €100 million per quarter. And so everything else will be accrued at 33%. That's not to be read definitively as an indication of our distribution intent. But as you point out, in respect of the €300 million for the first quarter is certainly a good start on our long-term distribution goals. And then lastly, on reg inflation, we called out the 80 basis points. What's encouraging is it's more certain. And I think the timing is now also somewhat more certain. I mean some of it could slip into Q3, but by and large, we now have visibility into that. It breaks down 50 basis points in the remaining TRIM impact, 20 basis points in CRR2 impacts and 10 basis points in EBA items, the definition of default, in particular. So those are the items. And I think we've got them now sized, and probably, from a timing perspective, fully built into our planning. You asked about the forward after that. If I refer you back to the -- my IDD presentation from December, we had -- on Slide 22, we see a little bit more inflation in '22, perhaps €5 billion, but then a pause until FRTB and some other items, which we assess at €25 billion in 2024, and we'd probably leave you for now with that guidance unchanged at this point. For the back half of the year, there are some movements on reg changes still expected. But we think at this point that those would be roughly neutral as we navigate to the year-end. I hope that all helps, Daniele.

The next question is from the line of Jeremy Sigee of Exane BNP Paribas.

A question on revenues and then a question on costs, please. Firstly, on revenues. I just wanted to follow up on your TLTRO comments. Does the €50 million you expect for 2Q, does that continue through 3Q and 4Q as well? And then how do you see the chances of getting a further benefit next year? Do you think it's likely that you can get the loan demand enough to earn that? So that's my first question. And then secondly, you talked quite a bit about costs in your comments. You're reducing underlying costs in line with the plan. You see some additional savings potential but you're also flagging upward pressure from bank levies and deposit guarantee schemes as well as upward pressure from volume and revenue related costs, which are a good thing. And you tell us that, that's P&L positive. But you're obviously sort of hinting at the possibility of revising your stated targets for 2021 and 2022. So I just wondered if you could talk a bit more about your thinking on how you balance those different cost drivers and what they could mean for the targets?

Jeremy, so I'll take both. Christian may want to add on the expenses. So TLTRO-III, as I mentioned, about €125 million of a kicker. So beyond the run rate benefit around the 50 basis points. And that kicker, we recognize on virtual certainty that we meet the loan commitments. And I think it's worth saying, we don't earn the money for free. It is -- the business is executing on lending, supporting clients that allows us to achieve those thresholds. But we did in Q1, we would expect to recognize, as I mentioned, €50 million incremental in Q2 and then a further €100 million in Q4, again, based on our estimates at this point on the virtual certainty test. And that's the amount above the ongoing benefit of 50 basis points. I will say at this point, we're -- we have about €41 billion of TLTRO-III drawn, so that's the volume that's driving those numbers. So a little bit of volatility, but helpful for the balance of the year and also into '22, to your point, given the extensions that were decided on in December. On the expense side, look, we have consistently spoken about executing on our reduction plans, and we've demonstrated at this point, a track record of over three years of meeting our goals. We mentioned that there are items out of our control that have arisen, the SRF and deposit insurance contributions, notably. But we've also been clear, and I said this in December, that we don't intend to offset those items in the cost line because we think we would starve the Company of necessary long-term investment capacity, especially in things like regulatory remediation, control remediation technology improvements. And we think that's the right call because these costs are essentially transitory. It does mean the…

I felt, really, James said it all. I simply want to support one thing. The discipline and focus in Deutsche Bank to reduce cost is as much there as it has been for the last three years. And I simply also want to remind you that for instance, the management changes which we have done right now is also intended to do some process and structural changes, i.e. , the integration of operations into the front office means we have a different front-to-back model, which obviously will result in further efficiencies. And this is exactly how James phrased it, that we do everything to work on additional measures and also to at least try to partially offset the uncontrollable items. And on the SRF, I can tell you also in my function as the B2B president, we will do everything to, again, advocate for that. Because we have more than €40 billion of funds unused there, which we could far better use for the European economy. And therefore, this debate is for us not over. We will continue to advocate.

The next question is from the line of Andrew Lim of Societe Generale.

Congrats on a great set of results. I've got three questions, if I may. So first of all, on NII sensitivity. So we've seen euro long rates increase. And I was just wondering if that's something that we can look forward to in terms of pushing up your NII higher at some point? I know you've given sensitivity analysis in your deck. But that's more apt to maybe the short-end and then longer than three months. So perhaps the 10-year and 20-year sensitivity might be something you could provide there. And then secondly, on SPACs, if we look to April, SPACs volume seems to have tailed off quite a bit. Just wondering what do you think the -- as the outlook, whether that's temporary due to regulatory issues? Or whether that's a new normal that we should expect going forward? And then thirdly, I can't not ask about Archegos. Obviously, you've ended up with surplus collateral. Just wondering if you could give your take here to how you've ended up in this really favorable position. Perhaps you could give a bit of color as to when you realized that you had to offload these positions, how fast you did that, and what kind of leverage maybe you offered to Archegos in relation to maybe other clients in Prime Brokerage?

Andrew, and I appreciate your comments. Look, on the curve, we -- as you point out, we provide our typical NII sensitivity disclosure on Page 37 of the deck. And I think that's actually a reasonably good measure. I get that the above three months doesn't tell you how much of it is truly out the curve. So the sensitivity is more in the five range of the curve. But we think that, that move in long rates and the 700 or so over two years is a good indication of what might come as long rates begin to move, especially in euro. We're very focused on managing curve risk, but we're also focused on maintaining some degree of sensitivity to movements in the long end of the curve, which is actually structurally, I think, part of our business.

And on the SPACs, I mean given the enormous dynamics surrounding this business, it is difficult to put a kind of a valid number on that also for the future quarters. We have a clear strategy. Our SPAC business is very differentiated. And as we said already, in January, we take on very high-quality clients, do it with high-quality partners, and don't so much look for leave tables on front ends. So I do believe also in that business, we will see a certain normalization. To your regulatory question, I cannot comment on that. But for sure, if you see a boom in certain businesses, you need to expect certain questions into a business. But I think we should also not underestimate that there is actually a good amount of ancillary business in that business, not only the starting point of SPAC, but then also the advisory business around it. And I think we are well positioned for that. So in the end, it's a good business for us. We select -- well, we are very selective on the partners and on the sponsors. But there is also ancillary business, which makes us quite confident also for the future. On Archegos, look, I think that at the end of the day, and I don't want to go too much into details here, but the risk management expertise, the way we have done our documentation, we have done our monitoring, the expertise we have in the second line of defense, but also in the first-line of defense in order to exit those situations is clearly speaking for Deutsche Bank. And we have done this business for years and years and years, and obviously, had similar situations before. I remember that when I was Chief Credit Officer, and I think simply, the way we have monitored the position, the way we have also enhanced documentation, increased certain requirements, put us into a position to exit it in a way we did, i.e., even handing back collateral.

The next question is from the line of Jernej Omahen of Goldman Sachs.

Well done on the results. I've just got a couple of questions left. So just this on Archegos. So can you just -- and I don't want to ask any specifics on the exposure, but can you just explain to us the risk from your former Prime Brokerage business, which was transferred to BNP, is that risk still with Deutsche Bank? And up until when does that risk stay with you? Because I think from your comments, it indicates that you've actively managed this position on your own behalf, I guess. And then the second question I have is on this deposit guarantee fees. Christian, you said we continue to advocate for change. And I was just wondering, in your mind, what is the range of possible outcomes? And over what time line do you think that they're achievable? I've got a long list of questions left, but I'll just ask one last one. So on this SPAC thing, is it fair to say that the ECM revenue, which I think came in at €196 million for the quarter, that this is where the SPAC revenue would sit? And then I think you yourself indicated that perhaps you expect this number to slow down a little bit. What should we expect this €200 million to be, given I think it's already at 50% pretty much of what it was last year?

So on the Prime Finance business, I'll start, and then I think Christian will take the other two questions. Yes, we are essentially operating the business on BNP Paribas' behalf. And so there is cost and revenue transfers that go with it. But naturally, it's impossible to manage a business, from a risk perspective, on two sides of a fence. And so we risk manage the balances, and therefore, the risk is with us. The encouraging thing, of course, is the outcome here. But the prime finance risks and electronic execution risks, as we see it, should be in an operating type level that -- and therefore, we had the confidence when we agreed to the transaction with BNP Paribas to move on that basis. And that's evidently what we were able to achieve in the quarter with this. We're very focused on the transfer. It's been a very successful process to date, and we're a few months away from completing that. But the partnership with BNP Paribas has been strong and was, if anything, strengthened by managing through this situation collaboratively.

And for sure. And I think it's remarkable that, obviously, you're one of the few banks that didn't incur a loss on their position. But just to get this straight, so the economic risk passes on to BNP at what point?

Yes. The benefits and burdens of the business, come the end of the year once the balances and client relationships have fully transferred to BNP Paribas, will be with BNP Paribas. While the client positions are on our balance sheet, we bear the risk of those client positions, hence, the importance of the risk management through to the completion of the transition.

Look, to your question on what options we have, I think, Jernej, it in particular refers to the SRF. I referred my comments with advocating to the SRF. Obviously, we are still advocating that the threshold should not be increased from €55 billion to approximately €72 billion or €75 billion, again, for the reasons that we think we can use and should use rather these funds differently in order to directly finance the European economy. That is number one. Number two is obviously the way of payment. We can also think about the usage of more irrevocable payment commitment instead of the direct P&L impact. I also made a proposal that the banks should actually, so to say, instead of paying into the fund paid directly into a fund which immediately generates credit facilities for European mid-cap companies so that we have a direct linkage into the economy. So there are various options which we discuss with the various stakeholders. And actually, there is also the willingness to listen to us and think about at least other alternatives. And hence, it is far too early to give up, and therefore, I wanted to make that point. On the SPAC business, again, I think we see, on the one hand, in particular in the origination of new SPACs, we will see a normalization. You're right. It is part of our ECM revenues. In my view, it is too early to judge what that could have an impact on the underlying revenues in the following quarters. Again, if there is a normalization, revenues in this regard would trend down a little bit. On the other hand, again, we have a second leg to the SPAC and that is the ancillary business in the O&A and in the advisory business. So that's very closely linked. And hence, I'm over comfortable with the outlook which we have given you for the full investment bank.

Next question is from the line of Adam Terelak of Mediobanca.

Yes. I wanted to follow up on NII. You gave guidance at the CMD last year on kind of the residual NII pressure. Rather than asking on the sensitivity, I was wondering how that residual pressure has changed with the steepening of the long end of the European and the U.S. yield curve, whether the amounts to come through the P&L this year is actually slightly lower now? So just some numbers about that would be great. And then I wanted a clarification on the LTRO booking. You've given the gross amount. Can we have that by division, and that gives us a bit more color of which revenue lines have been benefiting the most?

Thanks, Adam. Sure. So to the first answer, it's ever so slightly improved, at least in the current run rate and also the forward curves. So I wouldn't say a dramatic impact versus what we built into the plan last December. But what is encouraging is it's moving in the right direction. It had been steadily moving in the wrong direction in terms of increasing pressures. And now we see a bit of relief, especially, by the way, a little bit in '22, but the out years are improving by more, to the earlier question from Andrew. And hence, by the way, I was referring in the €700 million sensitivity to the euro, there's a little bit more on dollars as well. So we're encouraged about the direction of travel and the out years. In terms of the TLTRO, it's split about -- I'll give you round numbers, €50 million in each of PB and CB and about €25 million in the Investment Bank. And that split is based on essentially them earning it through the loan production. So that's how we've laid it out.

So the NII trajectory on a '21/22 view is little changed, but longer term, there's big upside.

Yes, a little bit of help. And the CB breakeven next year is something that is new to the picture with the change of curve. Again, it moved from a little bit positive to basically a little bit negative to basically flat. And then we do see an uplift from '23 onwards, which, again, is encouraging.

The next question is from the line of Amit Goel of Barclays.

So two follow-ups. So one, just in terms of the revenue outlook, at the Investor Day, I think there was some detail given for the FIC business in terms of sustainable revenues in 2020, the €6.4 billion number. Just curious, basically, if you can give us a bit more color in terms of which of the areas you anticipate the stronger performance to continue this year and whether that kind of sustainable level you think has then improved going into 2022? And the second question, just on the impairment charges. I think at that time also, you gave guidance of 25 to 30 bps for 2022, potentially with a higher level for 2021. With the revised -- or with the updated 2021 guidance, would you still expect a similar level in 2022 with less potential for write-backs at that point? Or would you also expect a lower normalized impairment charge as we go through to that period?

Look, on the sustainability of revenues, first of all, we would confirm the messages which we have given you on that day. I think it was Page 8 of Ram Nayak's presentation when he went through the waterfall of FIC. We have seen in Q1, obviously, versus Q1 2020, a very strong recovery in credit which was even stronger than we have anticipated. We have, on the other hand, seen a more normalization in the macro businesses in rates and at FX. But overall, I can assure you that the general trend of the underlying sustainabilities in revenues, be it in rates, in credit, FX and emerging markets is actually -- or we confirm the so-called -- the waterfall which we have indicated to you. And therefore, I think it is also based on the strong Q1, we will not change, obviously, our 2022 overall guidance for the Investment Bank. The only thing, based on the strong Q1 number, is an update of the outlook for the remainder or for the full year 2021. But the underlying momentum, the client engagement support us in our analysis where we said we have stabilized the business in the FIC and even started to grow, and a good part of that is sustainable business.

And then, Amit, on the CLP outlook, it's really too early to tell '22. We had called in December for a normalization of the CLP sort of run rate. And we, I think in the past, had indicated that we think that level normalized is somewhere between 20 and 25 basis points. Obviously, the improvement in the credit outlook has accelerated beyond what we thought was likely back in December. But that then puts us in an interesting place, whether some of the good news is brought forward to '21, and we -- or whether we continue on a run rate or something even better than the run rate level in '22, given the outlook for continued very strong economic performance. So too early to say, but we're following it, as you know, very carefully and continuing to focus on good underwriting, good risk management practices in the credit book.

Next question is from the line of Kian Abouhossein of JPMorgan.

First of all, congratulations on the great results, not just against the Swiss piece but also U.S. peers. First of all, on cost, you had a plan of €18.5 billion that DB discussed at the deep dive. For 2021, just wondering how you're thinking about that considering the uncontrollable costs. And for 2022, I understand the €16.7 billion remains a target, and clearly, there are some moving parts here. But can you discuss a little bit what the worst-case scenario could be, assuming worst-case scenario on these uncontrollable costs in order for us to get a feeling and understanding of what potentially the cost base could look like? And in that context, you took levies of €571 million in the first quarter. Just trying to understand how exactly that breaks down. And how -- what we should think about the annual charges here? The second question I have is just in relation to the revenues. You clearly have done a great job on NII, offsetting it with repricing, and you talked about that. I'm just trying to understand, with interest rates unchanged on the forward curves, more or less unchanged for the next two years, how should we think about your ability to offset that? I think you mentioned the 1% margin. Should we think that is sustainable? Or do you think real pricing or you're having the low-hanging fruits on repricing and that will be much more difficult in the next two years? And then the last question, if I may. Just to reconfirm, the €6. 4 billion FICC sustainable revenue number that you gave at the deep dive and Ram superbly explained, is that still the number we should think about sustainable revenues? Or should it be higher considering you're gaining market share?

So Kian, thanks for the questions and the comments. A lot to go through. Look, on the uncontrollables, I wouldn't want to paint a worst case. We're working through it. We're working through it on, as Christian mentioned, the advocacy around the Single Resolution Fund contributions, which going back to Jernej's question, it isn't a deposit guarantee fund. It's a solvency backstop, which is part of the reason we feel that it's sort of a strange thing to be growing the target with an increase in deposits in the system. How it breaks down, how do we get to €571 million, it's really based on the balance sheet as of the end of 2019. So it's a trailing sort of allocation methodology. It isn't totally transparent, but you obviously understand the definitions and the drivers broadly. The challenge for us is that bank levy is at least flat despite the simplification of the bank and the reduction in the balance sheet size. And so it's painful to be going through the restructurings and the improvement in the Company and yet seeing the increase in levy despite decreasing drivers. Thinking about your question on the net interest margin, obviously, we've been looking carefully at the impact of the curves. We feel more confident in the forward on that net interest margin in the two sort of deposit-heavy businesses, and hence, the guidance we provided. We do think that the combination of improving curves, deposit charging, balance sheet optimization and a lot of the other things we've talked about are giving us more confidence about a stabilization of the net interest margin in and around the 1%, maybe slightly over. And that feels solid to us. And so like a number of things, we think this quarter is, in a sense, calling a turn in some of the drivers that we've been battling against, net interest margins, one of them. By the way, capital is another, given the now greater visibility we have into the capital forward given the reg inflation items we talked about earlier.

And Kian, on your third question, let me put it this way. I would be very glad if you all would take our guidance from the Investor Day and take the €6.4 billion of sustainable revenues into your models because then we come closer to that what we are planning. So obviously, after Q1 and all the discussions we are having, we are not changing this outlook. We feel confirmed with this outlook, and if you go into this page on page 8, again, you even see certain initiatives to 2022 where we increased it to €6.7 billion in that business, which I can see is happening. Now I know this is obviously all about numbers. But having been 30 years with Deutsche Bank, never ever forget people's motivation if you have a certain momentum. And that's exactly what is happening in this bank. So therefore, we need to keep the focus. We need to keep the discipline. We need to follow up on our strategy, but with the momentum I see with the people coming day in, day out, working for this bank, of course in these days compared to three years ago, they take the next client call at 6:30 in the evening, which potentially people have not done three years ago. And that's exactly what is also a very, very important soft item, which completely brings confidence to me that we will make these numbers.

No, that's great to hear. Just to come back very briefly on cost. The target for 2022, if I remember correctly, had €400 million of levies in there, and your run rate is something like €600 million. Is that correct?

That's correct, Kian. And actually, there -- yes, that's correct, €600 million, maybe €700 million based on some definitional changes to do with our merger. And hence, again, the importance, the merger of the PFK entity into AG. And hence, again, the importance in our minds of advocacy around this point.

The next question is from the line of Magdalena Stoklosa of Morgan Stanley.

And again, congratulations on the quarter. It's great to see. I've got two questions, and they're both of revenues. I'm going to start with the Corporate Bank. Because I think that in the deep dive and throughout our conversations about the Corporate Bank over the last 18 months, and if we talked about the repricing measures, and of course, the bulk of it was on deposits. We've talked about kind of account fees. We've talked about kind of fee increases in various places. And of course, given the amount of deposits that you already kind of charge is way above the kind of targets that we have spoken about, could you kind of tell us about what is the ultimate target, how much of those €250 billion of the corporate deposits that you've got, you're likely to be able to reprice over a longer period of time? And of course, any other -- you've talked about payment fees from platforms, things like that. But anything else that you feel is going to make a real difference to that revenue line over the medium term? So that's my first question. And my second question really is on your idea, and I know we've kind of -- we've talked about it a lot. But really, when you talked about flat revenues year-on-year, and we look at the numbers, you've effectively made about $10.5 billion last year. You've made $3.7 billion, almost $3.8 in dollars in the first quarter, which effectively means that your cumulative nine months IB revenues from here can come down by 15% and you're actually going to be flat year-on-year. So my question really is, so there is quite a significant normalization in that remaining three quarters there. But how do you think about your mix within that scenario? Because, of course, you've got the dominant FICs that kind of tends to earn 75%, 80% of your IB revenues, and of course, you've got a broader capital markets and banking. Do you think that kind of -- that the banking side is likely to outperform FIC on a kind of relative basis in the next nine months to effectively also quite easily meet your $10.5 billion?

So Magdalena, thanks for the questions and also the commentary. I'd say there is still some distance to go in what we think is achievable in the charging. We tried to enhance the disclosure a little bit on page 35 of the deck this quarter to show where we're headed. It's obviously never going to be 100% of the book based on thresholds and other things that we apply to clients. But I think as we have continued down this path, we've seen more and more resonance, if you like, of the need for banks to be able to price this liquidity appropriately. And we think that in part is driven by changes in the competitive environment, but also in just the disciplined execution of the plans in the CB. And by the way, the same applies to the Private Bank. The charging agreements that we disclosed there are on interest revenues, but a lot of the repricing changes, we define as custody fees, and so don't hit the net interest line in PB. But as you can see, there's also significant scope in PB. So we're going to continue sort of executing on that, and we do think there's still an addressable deposit base in both the businesses.

And your second question, it's hard to say. First of all, I agree with your calculation, i.e., taking the first quarter and then remainder of the year. That makes us confident that we can achieve last year's numbers. You're right. And I think we always said and also in the prepared remarks that there is, in our view, a normalization across IB for the second, third and fourth quarter. Nevertheless, we can see a real strong underlying robustness of these revenues. We have, obviously, quite a good preview on the pipeline in O&A for, in particular now for the second quarter, but also what we are discussing, so to say, for the remainder of the year. We have a financing business, which we can obviously pretty well estimate what is coming there from the accrued business. And then that was the focus of our strategy, to be in the trading business there where we have a leading market position. And again, that ensures that we are either in the flow business or in the more structured business that we are as partner for our clients. And hence, we simply believe that there is an underlying flow and robustness of the revenues which makes us confident, including the great performance in Q1 to achieve the nine point -- the bigger 9 billion revenues in the IB in '21. A detailed distribution, too early to say.

The next question is from the line of Stuart Graham of Autonomous.

Congrats from me as well on the results. I had a question on yesterday's Bundesgrenzschutz ruling. What do you think the broader implications of that are, please? I guess looking forward, will it slow your repricing policy? And looking backwards, could you have to reimburse customers where you've raised fees, whether there's silent consent? And then two geeky numbers, please, for James. First in a few places, you referenced year-on-year FX impacts on revenues. Could you tell us how much FX benefited the adjusted costs year-on-year, please? And then secondly, can I just confirm you still got €8.2 billion of loans subject to COVID related for variance measures. I think that's on page 31 of the interim report. Is that correct?

So Stuart, and thanks as well. So yes, this ruling that you referred to is hot off the press, having been yesterday afternoon announced. So to be honest, we've had very little opportunity to analyze it. And we don't yet have the written reasoning for the decision. So there's a lot still to learn. And I will also point out that it came as a surprise to us given that we had won the case on the merits in the lower courts. Now importantly, this is an industry-wide issue. PostBank was the representative case about a general terms and conditions question in client documentation. So as you refer to, as I say, it's too hard to come up with a real assessment of the impact. But as you refer to, I would say, on the surface, it makes the work to implement pricing changes in the businesses affected by those contracts more administratively burdensome. But I wouldn't say that it would change our direction of travel in any way.

And Stuart, potentially to add on this point, again, it only came yesterday afternoon. So we have to really understand the details, but we should not underestimate that something like that can also have an opportunity in repricing overall. So I'm sure, as James is rightly pointing out, that is an industry issue that goes even beyond the banking industry. So I'm sure that people overall will review pricing, and that is also an opportunity.

Is it retrospective? Or it's just forward looking?

Well, it's, again, hard to say. The actual court case is defined as an injunction. And so it would be -- you'd interpret it as relating to the future. And certainly, we'd look at it that way. But again, we'll need to wait to see the written judgment and then react to that. On the numbers driven questions, in round numbers, the FX benefit would have been about $100 million a year, $100 million in the quarter relative to last year. That is beginning to also normalize in terms of a year-on-year. As you know, the interest -- the FX movement, now we've sort of lapped that or more or less lapped it. And then with respect to the forbearance, I'm not sure I understand your question precisely, but we have continued with the same disclosure in -- around moratoria and forbearance that you see in the earnings report. And if there's something I'm missing about your question, we're happy to follow up.

You just show it granted and active, and I just want to say which one of those are active. It looks like it's still €8.2 billion on the non moratoria on the voluntary forbearance measures?

Yes. I believe that's still an active number, but we can follow up to confirm.

The next question is from the line of Nicolas Payen of Kepler Cheuvreux.

The first one will be on credit loss provision. And I would be curious to know what would be the numbers you would have reported if you wouldn't have managed with your overlap that you did during the quarter? And then the second one is still on credit loss provision. Regarding your 25 bps cost of guidance for the full year, what kind of increase should we expect for the three remaining quarters? I mean is it increased from stage one on stage two or for stage three? And is it linked to the end of the state guarantee and supported by the end of the year?

Nicolas, so the overlay, there are moving parts. But first of all, we did remove the methodology overlay in Q1 that we applied last year. So the numbers are sort of normal course numbers now. I guess that's the first thing. The second thing is the forward-looking items or information adjustment was a release for us, as you've seen, I think, for a number of our peers. And by itself, that would -- release would have represented about €150 million in the quarter on change in economic outlook. There were other movements, which, as you can see, resulted -- were conservative on a net basis. And so meant that, that €94 millions came out in total of the stages one and two. But we feel really good about the allowance at this point, given all the history traveled and the adjustments that we've made, which leave us, I think, still in a very prudent place and with the allowance largely flat to the end of the year. As it relates to the 25 basis points, on the numbers, it would translate into a range around €1.1 billion for the year. Obviously, that would imply a pretty significant increase in the coming quarters in the credit costs. We hope that's conservative. But it would rely on incremental stage three impairment events, obviously, hard to predict. We've seen credit be more constructive recently. And also in that €165 million number were, in fact, some releases on earlier stage three impairments that went back to performing. In FLI terms, it depends on the future, but we would see that normalizing and perhaps creating a build just as you wash the very high GDP growth rates that you're expecting in the next couple of quarters out of the forward look. So there'd be some volatility from FLI. I hope that gives you some color as to what we're seeing.

The next question is from the line of Andrew Coombs of Citi.

One on fixed income, and then one more broadly on revenues. On fixed income, if I go back to Ram's slides at the Investor Day in December last year, you gave a useful split of the revenues by product over nine months '20. So at that point, credit and financing, I think, was 28% of overall revenues, so about 36% of fixed income revenues. Can you provide us with the equivalent number for Q1? Because I expect that credit and financing make up over half of your fixed income revenues, but I'd be grateful if you could confirm that. And then more broadly, with the target number that Ram outlined, the €8.5 billion by 2022, that assumes no increase in fixed financing revenues, whereas I'm assuming that's where you've had a big jump this quarter. So you are you expecting that to reverse? That's part of the first question. Second question, just a bigger picture question on revenues. I mean you've talked about the TLTRO-III kickers, that's €275 million that will step down next year. You've talked about SPAC revenues normalizing. You talked a bit about fixed income revenues normalizing. And yet you're guiding to €24 billion of revenues roughly for this year in your target for €24.4 billion. So somewhere there is some quite significant incremental revenues elsewhere that you are looking for in 2022. Can you just elaborate a bit more on where those revenues are going to come from?

So let me take your second question, the overall one. Again, I think if we talk about the €24.5 billion, and let's tackle the Investment Bank last, we have a very clear view on the achievements of our targets in all three business, Asset Management, Private Bank and Corporate Bank. And that is kind of more simple and easier to forecast, given that you very much base it on the existing volume, and the stability of the underlying revenues is obviously easier to forecast. Now looking again at that what the underlying strength and the underlying growth is in that business in Q1, that what we can see with the measures we have in place, be it deposit repricing, assets under management inflows, both in Asset Management, but also in private banking loan growth, which we see in the Corporate Bank, in the Private Bank, we simply feel very confident that we can achieve those numbers which we have indicated on the Investor Day. Some of those numbers which we have indicated for 2022, for instance in Asset Management, we might even achieve earlier. So there is a high degree of confidence. Now looking again at the Investment Bank, and I think now we are a little bit overestimating the impact, for instance, of the absolutely well-run SPAC business in Q1, but if you take it as an overall percentage of the total IB revenues, that business will not make or break the IB run in 2022. So we have a very strong underlying business in the FIC, in the credit business and also as we, in our view, have such a strong momentum in the client engagement Origination & Advisory that we simply think it's two years running above €9 billion of revenues. We feel confident to achieve the €8.5 million, in particular, with the analysis which we have given you in the IDD on the sustainability of revenues in FIC. And that we confirm today that we see that exactly like we told you in December, potentially even after Q1, slightly better. And there is -- for that reason, there is no way that we walk away from our revenue targets which we have given you there.

And Andrew, on your mix question, it's always very hard to predict the future on the mix and how it shifts over time. Obviously, Q1 was weighted more towards credit, both credit trading and financing, than is typical. And it also is -- it was particularly sort of impactful in the year-on-year comparison in the quarter. So without in any way diminishing what we think was good relative performance in rates, FX and emerging markets, the quarter was defined by a strong credit performance. The mix going forward is, as I say, hard to judge. What we like about our business is the portfolio nature of it. So you get to places where each of the businesses is performing in line with its market opportunity driven by volatility, driven by client activity, driven by the mix of structured versus flow business. But seeing the interaction then as the mix develops, you do get some comfort about the trend and the direction of travel, even as the mix can be a little bit unpredictable from quarter-to-quarter. And of course, the year-on-year comparisons can move from quarter-to-quarter.

And the final question is from the line of Anke Reingen of RBC.

I just wanted to follow-up on capital and capital return. You said this is a changed quarter. Obviously now with a 33% accrual, it is a little bit less theoretical. I just wanted to ask, if you can give us a bit of an update in terms of how you're thinking it. At 33%, when are you considering adding a buyback to it, we expect this for full year results or what the overall mix is? And then also, probably acquisitions. Now as you said, you're largely done with your own transformation. Where do you think you would like to -- if you would be looking, what areas would you be thinking of? It is like cost cutting? Or would it be more like asset-light, where you basically think you could create value for shareholders for -- if you do a bolt-on or a deal, and what quite the area you'd be looking at?

Thank you, Anke. And so as I mentioned, the dividend accrual is mechanical based on a rule, but the nice thing is to exit the first quarter with the €300 million sort of on the books represents a €0.15 dividend just on that, if it were all to come out in dividend. I think that gives us some flexibility as we think to the -- both the size and the mix of the distribution that we intend to start next year. But it's too early to say, as I say, on both size and mix, but we're pleased that we've set a milestone here. It does also, as you point out, the greater certainty we have about the capital path does potentially open the door to undertaking smaller acquisitions with more confidence and the capital to support them. I wouldn't tell you that, that made it more imminent, if you like, but it definitely helps with confidence about the capital impact of potential acquisitions.

And Anke, on your second question, if I can slightly correct that, I think James and I will do a very bad job if we are saying the transformation is largely over. We have half time, and we need to keep the focus into the discipline. There is lots to do on everything, be it revenues, be it cost. So we are fully focused on that. And we certainly believe, and fortunately, we have seen that over the last 12 months with each quarter where we perform, we get better also in relative terms, and that is then the right basis for any other discussion. But for the time being, 100% focus only on our transformation.

In the interest of time, we have to stop the Q&A session, and I hand back to Ioana Patriniche for closing comments.

Thank you, operator, and thank you for your questions and for joining the call today. And as ever, the IR team remains at your disposal for any follow-up questions you may have. So please don't hesitate to reach out. And with that, we look forward to speaking to you at our second quarter call in July.